Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
Shahid A. Khan(Imperial College London), Harpreet Wasan(Peter MacCallum Cancer Centre), Andrew V. Thillainayagam(Imperial College London), Brian R Davidson(The Royal Free Hospital), Robert Goldin(Imperial College London), Simon D. Taylor‐Robinson(Imperial College London), Stephen P. Pereira(University College London Hospitals NHS Foundation Trust), William Rosenberg(University College London), Howard C. Thomas(St Mary's Hospital), Mark Thursz(St Mary's Hospital)
Cited by 645
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
|The Lancet|1989|1.2k
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k